Back
Results - Announcements
Sales rise 13.01% to Rs 3.30 crore
Brawn Biotech reports standalone net loss of Rs 0.34 crore in the September 2024 quarter
14-Nov-2024, 05:48
Net Loss of Brawn Biotech reported to Rs 0.34 crore in the quarter ended September 2024 as against net loss of Rs 0.42 crore during the previous quarter ended September 2023. Sales rose 13.01% to Rs 3.30 crore in the quarter ended September 2024 as against Rs 2.92 crore during the previous quarter ended September 2023.
Net Loss of Brawn Biotech reported to Rs 0.34 crore in the quarter ended September 2024 as against net loss of Rs 0.42 crore during the previous quarter ended September 2023. Sales rose 13.01% to Rs 3.30 crore in the quarter ended September 2024 as against Rs 2.92 crore during the previous quarter ended September 2023.
| Particulars | Quarter Ended | ||
| Sep. 2024 | Sep. 2023 | % Var. | |
| Sales | 3.30 | 2.92 | 13 |
| OPM % | -9.39 | -13.36 | - |
| PBDT | -0.31 | -0.39 | 21 |
| PBT | -0.34 | -0.42 | 19 |
| NP | -0.34 | -0.42 | 19 |
Powered by Capital Market - Live News